Ad26.cov2-s/elasomeran/tozinameranEye disorders: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1933卷 / 1期

关键词：

D O I：

10.1007/s40278-022-27968-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：17 / 17

相关论文

共 50 条

[1] Ad26.cov2-s/elasomeran/tozinameranAcute myocarditis: 4 case reports
Reactions Weekly, 2023, 1952 (1) : 27 - 27
[2] Ad26.COV2-S/elasomeran/tozinameranMyocarditis: 7 case reports
Reactions Weekly, 2022, 1917 (1) : 23 - 24
[3] Ad26.cov2-s/elasomeran/tozinameranAnaphylaxis: 8 case reports
Reactions Weekly, 2023, 1946 (1) : 17 - 17
[4] Ad26.COV2-S/elasomeran/tozinameranMyocarditis: 7 case reports
Reactions Weekly, 2022, 1903 (1) : 20 - 20
[5] Ad26.COV2-S/Elasomeran/TozinameranThrombotic thrombocytopenia: 3 case reports
Reactions Weekly, 2024, 2024 (1) : 18 - 18
[6] Ad26.cov2-s/elasomeran/tozinameranPerimyocarditis and pericarditis: 10 case reports
Reactions Weekly, 2022, 1936 (1) : 18 - 18
[7] Ad26.cov2-s/elasomeran/tozinameranAcute myocarditis: 7 case reports
Reactions Weekly, 2023, 1938 (1) : 32 - 32
[8] Ad26.cov2-s/elasomeran/tozinameranThrombotic thrombocytopenic purpura: 37 case reports
Reactions Weekly, 2022, 1914 (1) : 20 - 20
[9] Ad26.cov2-s/elasomeran/tozinameranVaccine breakthrough infection: 76 case reports
Reactions Weekly, 2022, 1897 (1) : 21 - 21
[10] Ad26.cov2-s/elasomeran/tozinameranMyocarditis, pericarditis and myopericarditis: 11 case reports
Reactions Weekly, 2023, 1963 (1) : 20 - 20

← 1 2 3 4 5 →